KNBIF (Kane Biotech) Short-Term Capital Lease Obligation : $0.08 Mil (As of Dec. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Kane Biotech Short-Term Capital Lease Obligation?

Kane Biotech's Short-Term Capital Lease Obligation for the quarter that ended in Dec. 2024 was $0.08 Mil.

Kane Biotech's quarterly Short-Term Capital Lease Obligation increased from Jun. 2024 ($0.08 Mil) to Sep. 2024 ($0.09 Mil) but then declined from Sep. 2024 ($0.09 Mil) to Dec. 2024 ($0.08 Mil).

Kane Biotech's annual Short-Term Capital Lease Obligation increased from Dec. 2022 ($0.08 Mil) to Dec. 2023 ($0.08 Mil) but then stayed the same from Dec. 2023 ($0.08 Mil) to Dec. 2024 ($0.08 Mil).

Kane Biotech Short-Term Capital Lease Obligation Historical Data

The historical data trend for Kane Biotech's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kane Biotech Short-Term Capital Lease Obligation Chart

Kane Biotech Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

0.04

0.10

0.08

Kane Biotech Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															0.08	0.08	0.08	0.09	0.08

Kane Biotech Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Kane Biotech Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Kane Biotech's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Kane Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kane Biotech Inc (OTCPK:KNBIF) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

KNE:Canada

Address

290-100 Innovation Drive, Winnipeg, MB, CAN, R3T 6G2

Website

https://www.kanebiotech.com

Kane Biotech Inc is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The company has a portfolio of biotechnologies, intellectual property and products developed by its own biofilm research expertise and acquired from research institutions. The company's operating segments are animal health and human health. It derives maximum revenue from Animal health segment.